Answers are grounded in this paper and cite their sources.
Thyrotrophin-releasing hormone and gonadotrophin-releasing hormone were measured in lumbar CSF from patients with idiopathic senile dementia, cerebral tumours and spinal disc lesions. Somatostatin was also measured in lumbar CSF from patients with dementia and patients with other neurological disorders, but the numbers involved were much smaller. The levels of these neuropeptides were significantly reduced in the patients with senile dementia. These results suggest a possible involvement of hpothalamic neuropeptides in idiopathic senile dementia.
No takes yet. Share an insight, caveat, or question.
Oram et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: